In vitro assays demonstrated that NGB alleviates sevoflurane-triggered mitochondrial damage and neuronal death via two separate cascades: NGB restores mitophagy and suppresses ferroptosis by interacting with and positively regulating the protein expression of YTHDF3, whereas its intrinsic antioxidant activity improves cell viability and eliminates ROS in a YTHDF3-independent manner.
Abstract
Sevoflurane-induced developmental neurotoxicity is characterized by impaired mitophagy and excessive ferroptosis. Neuroglobin (NGB) exerts broad neuroprotective effects, yet its exact epitranscriptomic regulatory mechanism against sevoflurane injury remains elusive. Two complementary experimental systems with identical total sevoflurane exposure length were adopted for in vitro mechanistic exploration and in vivo physiological verification, respectively. HT22 hippocampal neurons underwent uninterrupted 6 h sevoflurane incubation, while neonatal rats received 2 h intermittent inhalation each day for three consecutive days. We constructed lentiviral systems to overexpress or knockdown NGB/YTHDF3, then detected cell viability, mitochondrial function, reactive oxygen species (ROS), iron levels and pathway biomarkers. Co-immunoprecipitation verified endogenous protein interaction between NGB and m6A reader YTHDF3, and in vivo experiments further detected hippocampal mitophagy, ferroptosis indicators and mitochondrial ultrastructure. In vitro assays demonstrated that NGB alleviates sevoflurane-triggered mitochondrial damage and neuronal death via two separate cascades: NGB restores mitophagy and suppresses ferroptosis by interacting with and positively regulating the protein expression of YTHDF3, whereas its intrinsic antioxidant activity improves cell viability and eliminates ROS in a YTHDF3-independent manner. Collectively, this study describes a NGB-YTHDF3 epitranscriptomic regulatory mechanism that mitigates sevoflurane-triggered developmental neurotoxicity and offers therapeutic insights for pediatric brain protection.
Findings identify a tractable molecular interface for precision modulation of ferroptosis in ICH, and reveal an unexpected context dependence within the Lcn2‐Nrf2 signaling axis.
Ya-Nan Dou, Hong-Kang Hu, Qinghua Li et al.· MedComm· 0 citations
Cerebral ischemia-reperfusion injury (CIRI) is a leading cause of neurological disability with few effective therapeutic strategies, and ferroptosis has been proven to participate in CIRI progression while its upstream regulatory mechanisms remain poorly defined. Herein, we performed transcriptomic analysis on GSE16207...
Hai-Ning Wang, Bai-Chao Han, Chen Xu et al.· Archives of Biochemistry and...· 0 citations
These findings identify the PGAM5/VDAC1 axis as a key mechanism linking ponatinib stress to coordinated failure of MQC in the heart and targeting PGAM5-dependent VDAC1 oligomerization may represent a potential strategy for limiting ponatinib-associated cardiotoxicity.
It is demonstrated that BPA activates the AMPK/mTOR/ULK1 signaling pathway to promote NCOA4‑mediated ferritinophagy, leading to ferroptosis in HT‑22 cells.
Yue Zhang, Yuxin Wang, Ping He et al.· Toxicology Letters· 0 citations
Intracerebral hemorrhage (ICH) is a devastating neurological disorder characterized by extensive neuronal death, in which ferroptosis has emerged as a central pathological mechanism. Yet, the role of mitophagy in regulating ferroptosis during ICH remains elusive. Herein, we identified a lactylation-mediated HSPA5 (heat...
Qi-Xiang Zhang, Qi-Kai Tang, Bao-Feng Wang et al.· Autophagy· 0 citations
Cisplatin–induced ototoxicity is a significant clinical issue linked to ferroptosis and mitophagy dysfunction. This study investigated how mitophagy regulates ferroptosis in cisplatin–induced hearing loss using cultured primary rat cochlear marginal cells in vitro and a C57BL/6J mouse model of cisplatin–induced ototoxi...
Ting Li, Wen-Ting Yu, Huan-Zhi Wan et al.· Cells· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.